Cargando…
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
PURPOSE: The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786307/ https://www.ncbi.nlm.nih.gov/pubmed/26963909 http://dx.doi.org/10.1371/journal.pone.0149072 |
_version_ | 1782420535264673792 |
---|---|
author | Kluge, Regine Chavdarova, Lidia Hoffmann, Martha Kobe, Carsten Malkowski, Bogdan Montravers, Françoise Kurch, Lars Georgi, Thomas Dietlein, Markus Wallace, W. Hamish Karlen, Jonas Fernández-Teijeiro, Ana Cepelova, Michaela Wilson, Lorrain Bergstraesser, Eva Sabri, Osama Mauz-Körholz, Christine Körholz, Dieter Hasenclever, Dirk |
author_facet | Kluge, Regine Chavdarova, Lidia Hoffmann, Martha Kobe, Carsten Malkowski, Bogdan Montravers, Françoise Kurch, Lars Georgi, Thomas Dietlein, Markus Wallace, W. Hamish Karlen, Jonas Fernández-Teijeiro, Ana Cepelova, Michaela Wilson, Lorrain Bergstraesser, Eva Sabri, Osama Mauz-Körholz, Christine Körholz, Dieter Hasenclever, Dirk |
author_sort | Kluge, Regine |
collection | PubMed |
description | PURPOSE: The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination between score D1,2,3 and score D4,5. Inter-reader reliability of the whole scale is not well characterised. METHODS: Five international expert readers scored 100 interim PET/CT scans from paediatric HL patients. Scans were acquired in 51 European hospitals after two courses of OEPA chemotherapy (according to the EuroNet-PHL-C1 study). Images were interpreted in direct comparison with staging PET/CTs. RESULTS: The probability that two random readers concord on the five point D score of a random case is only 42% (global kappa = 0.24). Aggregating to a three point scale D1,2 vs. D3 vs. D4,5 improves concordance to 60% (kappa = 0.34). Concordance if one of two readers assigns a given score is 70% for score D1,2 only 36% for score D3 and 64% for D4,5. Concordance for the binary decisions D1,2 vs. D3,4,5 is 67% and 86% for D1,2,3 vs D4,5 (kappa = 0.36 resp. 0.56). If one reader assigns D1,2,3 concordance probability is 92%, but only 64% if D4,5 is called. Discrepancies occur mainly in mediastinum, neck and skeleton. CONCLUSION: Inter-reader reliability of the five point D-scale is poor in this interobserver analysis of paediatric patients who underwent OEPA. Inter-reader variability is maximal in cases assigned to D2 or D3. The binary distinction D1,2,3 versus D4,5 is the most reliable criterion for clinical decision making. |
format | Online Article Text |
id | pubmed-4786307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47863072016-03-23 Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma Kluge, Regine Chavdarova, Lidia Hoffmann, Martha Kobe, Carsten Malkowski, Bogdan Montravers, Françoise Kurch, Lars Georgi, Thomas Dietlein, Markus Wallace, W. Hamish Karlen, Jonas Fernández-Teijeiro, Ana Cepelova, Michaela Wilson, Lorrain Bergstraesser, Eva Sabri, Osama Mauz-Körholz, Christine Körholz, Dieter Hasenclever, Dirk PLoS One Research Article PURPOSE: The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination between score D1,2,3 and score D4,5. Inter-reader reliability of the whole scale is not well characterised. METHODS: Five international expert readers scored 100 interim PET/CT scans from paediatric HL patients. Scans were acquired in 51 European hospitals after two courses of OEPA chemotherapy (according to the EuroNet-PHL-C1 study). Images were interpreted in direct comparison with staging PET/CTs. RESULTS: The probability that two random readers concord on the five point D score of a random case is only 42% (global kappa = 0.24). Aggregating to a three point scale D1,2 vs. D3 vs. D4,5 improves concordance to 60% (kappa = 0.34). Concordance if one of two readers assigns a given score is 70% for score D1,2 only 36% for score D3 and 64% for D4,5. Concordance for the binary decisions D1,2 vs. D3,4,5 is 67% and 86% for D1,2,3 vs D4,5 (kappa = 0.36 resp. 0.56). If one reader assigns D1,2,3 concordance probability is 92%, but only 64% if D4,5 is called. Discrepancies occur mainly in mediastinum, neck and skeleton. CONCLUSION: Inter-reader reliability of the five point D-scale is poor in this interobserver analysis of paediatric patients who underwent OEPA. Inter-reader variability is maximal in cases assigned to D2 or D3. The binary distinction D1,2,3 versus D4,5 is the most reliable criterion for clinical decision making. Public Library of Science 2016-03-10 /pmc/articles/PMC4786307/ /pubmed/26963909 http://dx.doi.org/10.1371/journal.pone.0149072 Text en © 2016 Kluge et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kluge, Regine Chavdarova, Lidia Hoffmann, Martha Kobe, Carsten Malkowski, Bogdan Montravers, Françoise Kurch, Lars Georgi, Thomas Dietlein, Markus Wallace, W. Hamish Karlen, Jonas Fernández-Teijeiro, Ana Cepelova, Michaela Wilson, Lorrain Bergstraesser, Eva Sabri, Osama Mauz-Körholz, Christine Körholz, Dieter Hasenclever, Dirk Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma |
title | Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma |
title_full | Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma |
title_fullStr | Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma |
title_full_unstemmed | Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma |
title_short | Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma |
title_sort | inter-reader reliability of early fdg-pet/ct response assessment using the deauville scale after 2 cycles of intensive chemotherapy (oepa) in hodgkin’s lymphoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786307/ https://www.ncbi.nlm.nih.gov/pubmed/26963909 http://dx.doi.org/10.1371/journal.pone.0149072 |
work_keys_str_mv | AT klugeregine interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT chavdarovalidia interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT hoffmannmartha interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT kobecarsten interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT malkowskibogdan interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT montraversfrancoise interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT kurchlars interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT georgithomas interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT dietleinmarkus interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT wallacewhamish interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT karlenjonas interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT fernandezteijeiroana interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT cepelovamichaela interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT wilsonlorrain interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT bergstraessereva interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT sabriosama interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT mauzkorholzchristine interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT korholzdieter interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma AT hasencleverdirk interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma |